Trials / Completed
CompletedNCT03788577
Impact of Oligonol to Cardiometabolic Risk and Muscular Health
Impact of Oligonol to Cardiometabolic Risk and Muscular Health: a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- National Yang Ming Chiao Tung University · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This project will mainly focus on Middle and old-aged adults, and examine whether Cardiovascular and metabolic risks can be reduced. In the meanwhile, this project will develop strategies for improving muscle loss , muscle strength decline, and the quality life of the elderly.
Detailed description
Cardiovascular diseases are common among the elder. However, previous researches mainly focus on observational research or small scale clinical trial, and the subjects are mainly youth. Therefore, this project hope to understand whether Oligonol can reduce Cardiovascular and metabolic risks among senior adults. Consequently,improve muscle loss muscle strength decline, quality of old adults life. This project design may potentially develop new strategies for curing Sarcopenia as well.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oligonol intake | Major intervention of Oligonol component , as suggested Oligonol safe dose for adults is 200mg per day. |
| DIETARY_SUPPLEMENT | Placebo | Placebo |
Timeline
- Start date
- 2018-12-04
- Primary completion
- 2020-04-01
- Completion
- 2020-04-01
- First posted
- 2018-12-27
- Last updated
- 2023-04-14
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03788577. Inclusion in this directory is not an endorsement.